Learn More
Invitrogen™ Silencer™ Human Drug Targets siRNA Library (384 well)
Description
The Silencer™ Human Drug Targets siRNA Library includes genes involved in apoptosis, senescence, nucleic acid binding, autophagy, DNA repair, and along with characterized nuclear receptors and other genes that are considered potential targets for therapeutics. The Silencer Human Drug Targets siRNA Library contains 23,745 Ambion™ Silencer siRNAs targeting 7,915 genes for performing RNAi screens against known human drug target genes. The library was designed using the most up-to-date genome databases, including the NCBI RefSeq database and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).
Utilizing Invitrogen Silencer technology built on stringent bioinformatics to enable high target specificity and siRNA potency, the Silencer Human Drug Targets siRNA Library is an ideal solution for focused and cost-effective RNAi screening against pre-defined therapeutic gene drug targets .
- Comprehensive—Expedite your drug target screens with pre-defined libraries of Silencer human drug targets siRNAs
- Reliable—Increase target screening accuracy with three individual siRNAs per gene targetEffective—Reduce off target impacts at low concentrations with proven Invitrogen Silencer siRNA design
- Convenient—Reduce data de-convolution and accelerate target validation with our 96-and 384-well arrayed format
- Customizable—Choose the best option for your workflow demands, including additional siRNA scales and pooled formats
Specifications
Specifications
| Description | 23,745 total siRNAs targeting 7915 genes plated onto 384-well plates (69 plates) |
For research use only. Not for use in diagnostic procedures
Your input is important to us. Please complete this form to provide feedback related to the content on this product.